Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Transfusional Hemosiderosis/Transfusional Iron Overload |
Dose: Oral – 20 mg/kg Frequency: once daily Note: Indicated for the treatment of chronic iron overload caused by blood transfusion; may increase by 5-10 mg increments based on serum ferritin; if not controlled on 30 mg/kg/day (ie, serum ferritin persistently greater than 2500 mcg/L), may increase up to 40 mg/kg once daily |
|
Indication: Nontransfusion-Dependent Thalassemia Condition: liver iron concentration of at least 5 mg Fe per gram of dry weight and a serum ferritin greater than 300 mcg/L |
Dose: Oral Tablet – 10 mg/kg Frequency: once daily Note: Indicated for treatment of chronic iron overload caused by nontransfusion-dependent thalassemia syndromes; calculate dose to nearest tablet size; if liver iron concentration greater than 15 mg Fe/g dry weight after 4 weeks, consider increasing dose to 20 mg/kg/day |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Transfusional Hemosiderosis/Transfusional Iron Overload Age: less than 2 years |
Dose: Oral – Not established Note: Safety and efficacy not established |
|
Indication: Transfusional Hemosiderosis/Transfusional Iron Overload |
Dose: Oral – 20 mg/kg Frequency: once daily Note: may increase by 5-10 mg increments based on serum ferritin; if not controlled on 30 mg/kg/day (ie, serum ferritin persistently greater than 2500 mcg/L), may increase up to 40 mg/kg once daily |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Creatinine Clearance 40-60 mL/minute |
Dose: Not specified Note: Reduce starting dose by 50% |
|
Condition: Serum Creatinine greater than 2 x Upper Limit of Normal or Creatinine Clearance less than 40 mL/minute |
Dose: Not specified Note: Do not use |
Administration
- Take on empty stomach
- Take 30 minutes before meals
Side Effect
- serum creatinineeatinine increase (dose related
- 7-38%)
- Abdominal pain (21-28%)
- Nausea (11-23%)
- Vomiting (10-21%)
- Diarrhea (12-20%)
- Proteinuria (19%)
- Pyrexia (19%)
- Headache (16%)
- Cough (14%)
- Nasopharyngitis (13%)
- Pharyngolaryngeal pain (11%)
- Influenza (11%)
- Rash (8-11%)
- Respiratory tract infection (10%)
- Bronchitis (9%)
- ALT increased (2-8%)
- Arthralgia
- back pain (6-7%)
- Acute tonsillitis (6%)
- Rhinitis (6%)
- Fatigue (6%)
- Ear infection (5%)
- Transaminitis (4%)
- Urticaria (4%)
- Anaphylaxis
- Angioedema
- Cytopenias
- including agranulocytosis
- neutropenia and thrombocytopenia
- leukocytoclastic vasculitis
- Acute renal failure
- serious hypersensitivity reactions such as angioedema and anaphylaxis
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Aluminium-containing antacids
|
Not to be used together as it may chelate aluminium
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general drug reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store at 25° C. Protect from moisture.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.